Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Over-the-counter statins: benefit or harmful?].

I Guessous1, N Rodondi, F Paccaud

  • 1Institut universitaire de médecine sociale et préventive IUMSP, Unité d'evaluation des soins UES, Rue du Bugnon 17, 1005 Lausanne. Idris.Guessous@hospvd.ch

Revue Medicale Suisse
|December 3, 2005
PubMed
Summary

Making statin available over-the-counter (OTC) may address underuse, but efficacy and safety concerns for 10mg simvastatin in primary prevention require experimental evaluation before wider introduction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory predictors of Post-COVID fatigue.

Brain, behavior, & immunity - health·2025
Same author

Systemic cytokines related to memory function 6-9 months and 12-15 months after SARS-CoV-2 infection.

Scientific reports·2024
Same author

Biopsychosocial risk factors for subjective cognitive decline among older adults during the COVID-19 pandemic: a population-based study.

Public health·2024
Same author

Antipsychotic prescribing and drug-related readmissions in multimorbid older inpatients: a post-hoc analysis of the OPERAM population.

International journal of clinical pharmacy·2024
Same author

Long-term trajectories of densely reported depressive symptoms during an extended period of the COVID-19 pandemic in Switzerland: Social worries matter.

Comprehensive psychiatry·2024
Same author

French-speaking Swiss physician's perceptions and perspectives regarding their competencies and training need in leadership and management: a mixed-methods study.

BMC health services research·2023

Area of Science:

  • Pharmacology
  • Public Health
  • Cardiology

Context:

  • Simvastatin 10 mg became available over-the-counter (OTC) in Great Britain in May 2004.
  • This initiative aimed to combat statin underuse and reduce coronary heart disease mortality.
  • Concerns exist regarding the efficacy of low-dose statins in primary prevention and potential drug interactions.

Purpose:

  • To evaluate the potential benefits and risks of switching statins from prescription to OTC status.
  • To address uncertainties surrounding the efficacy of 10 mg simvastatin for primary prevention.
  • To explore the implications of OTC availability on individual health responsibility and healthcare costs.

Summary:

  • The OTC availability of simvastatin 10 mg in Great Britain presents a strategy to increase statin use.

Related Experiment Videos

  • However, significant questions remain about its effectiveness for primary prevention and the safety profile at this dosage.
  • Experimental evaluation is recommended before broader implementation of OTC statin access.

    • Impact:

    • Potential to increase access to cholesterol-lowering medication and empower individuals in managing their cardiovascular health.
    • Highlights the need for rigorous assessment of OTC medications to balance accessibility with patient safety.
    • May influence future pharmaceutical policies regarding prescription-to-OTC switches for chronic disease management.